| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MIRA | MIRA PHARMACEUTICALS, INC. | Director | Aug 17, 2023 | |||
| TELO | Telomir Pharmaceuticals, Inc. | General Counsel, Director | Feb 8, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|